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Abstract 
 
Background: Aster tataricus L. f. is used as a traditional Chinese drug to relieve cough and asthma symptoms and to eliminate 
phlegm. However, Aster tataricus L. f. possesses toxicity, and little systematic research has been conducted on its toxic effects in the 
laboratory. 
Methods and Materials: The acute group was administered 75% alcohol extract of Aster tataricus L. f. in a single dose. A 
subchronic toxicity study was performed via daily oral administration of Aster tataricus L. f. at a dose of 0.34 g/kg body weight in 
SD rats. The rats were divided into six groups: a petroleum ether extract (PEA) group, an ethyl acetate extract (EEA) group, an 
n-butyl alcohol extract (NEA) group, a remaining lower aqueous phases (REA) group, a 75% alcohol extract (AEA) group and a 
control group. Quantitative measurements of cytokines were obtained by fluorescence with a laser scanner using a Cy3 equivalent 
dye.  
Results: The LD50 of the 75% alcohol extract of Aster tataricus L. f. was 15.74 g/kg bw. In the subchronic toxicity study, no 
significant differences were observed among groups in relative organ weights, urine traits, liver antioxidase levels, or cytokine levels. 
However, significant sporadic differences were observed in body weight gains, haematology indices, biochemistry values, and 
histopathology features in PEA, EEA group. In addition, sporadic changes in other groups in measures such as WBC, MCHC, CK, 
ALP, AST, ALT, LDH, T-BIL, LDL-C, HDL-C, and TC were observed. 
Conclusion: The toxicity study showed that Aster tataricus L. f. can produce toxic effects, mainly on the liver; much less on the 
heart. The LD50 was 15.74 g/kg BW in mice, and the subchronic toxicity study, used a dosage of 0.34 g/kg/d.BW, showed that the 
toxic components of Aster tataricus L. f. were mainly concentrated in the petroleum ether fraction, followed by the ethyl acetate 
fraction, the n-butyl alcohol fraction, the lower aqueous phase and the 75% ethanol extracts.  
 
Keywords: Aster tataricus L. f.; Acute toxicity; Subchronic toxicity; Cytokines; Hepatic injury 
 
Abbreviations: PEA, petroleum ether extract of Aster tataricus L. f.; EEA, ethyl acetate extract of Aster tataricus L. f.; 
NEA: n-butyl alcohol extract of Aster tataricus L. f.; REA: lower aqueous phases of Aster tataricus L. f.; AEA, 75% alcohol extract 
of Aster tataricus L. f.; WBC, white blood cell; RBC, red blood cell, PLT, platelet; HCT, haematocrit; MCV, mean corpuscular 
volume; HGB, haemoglobin; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration; CREA, 
creatinine; LDH, lactate dehydrogenase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; 
T-BIL, total bilirubin; ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; TP, total protein; 
ALB, albumin; Glu, glucose; TC, total cholesterol; TG, triglycerides; CK, creatine kinase; GSH, Glutathione; MDA, 
malondialdehyde; T-SOD, total superoxide dismutase; TNF, tumour necrosis factor; IFN, interferon; MCP, monocyte chemotactic 
protein C. 
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Introduction 
 
Aster tataricus L. f., a perennial herb of the Asteraceae (Morita et al., 1996), is widely distributed across Asia, Europe and 
North America. Majority of Aster species grow in low-lying wetlands, hills and low mountain meadows and marshes. There are an 
estimated 250 species of Aster worldwide, including 100 species that occur in China. A variety of compounds have been isolated 
from Aster tataricus L. f., including coumarins, flavonoids, anthraquinones (Sawai et al., 2011), sterols, peptides, terpenes (Akihisa 
et al., 1999), sesquiterpenes, astersaponin (Zhou et al., 2014), a triterpene and epifriedelinol (Fujioka et al., 1997; Shirota et al., 
1994). A number of volatile oil constituents have been identified in Aster tataricus L. f. by gas chromatography (Tori et al., 2001).  
However, in China, shionone is known as the main triterpenoid component of Aster tataricus L. f. The dried roots of this plant 
have been used in traditional Chinese medicine to eliminate phlegm and relieve cough (Sawai et al., 2011). Aster tataricus L. f. has 
been used as an expectorant, and it possesses diuretic, antibacterial, antitumour, antiviral and anti-ulcer activities (Morita et al., 1996; 
Shao et al., 1997; Wang et al., 1998). Yen et al. (1998) demonstrated that emodin, a component of Aster tataricus L. f., has 
antioxidant properties. Ng et al. (2003) showed that quercetin and kaempferol are effective antioxidants for inhibiting erythrocytic 
haemolysis and brain lipid peroxidation and that quercetin, kaempferol, scopoletin and emodin can inhibit the formation of 
superoxide free radicals. Additionally, terpene can cause cytotoxicity in tumour cells by inducing tumour cell apoptosis and DNA 
mutations (Zhou et al., 2014). In recent years, studies of the pharmacological activity of Aster tataricus have focused on cough relief 
and phlegm elimination or its anti-tumour effects, with few assessments of other pharmacological activities and no reports on liver 
toxicity associated with Aster. Considering its pharmacological activities and potential health benefits, and the lack of toxicological 
studies, there is a pressing need to clarify the toxicological profile of Aster tataricus L. f. Thus, we evaluated the LD50 and potential 
toxic effects of a 75% alcohol extract and four organic agentia extracts (petroleum ether extract, ethyl acetate extract, n-butyl alcohol 
extract, and aqueous phases) of Aster tataricus L. f. over 91 days to identify the extract with the greatest toxicity and determine the 
relationship between the toxicity and the duration of oral dosing. Haematology, biochemistry, urinalysis, liver biochemistry, 
histopathology, inflammation array, weight change and organ-to-body weight ratio were evaluated.  
 
Materials and methods 
Materials and Chemicals    
 
Urine was examined by using a KNF-100 Automated Urine Chemistry Analyser (Uritest Inc., China). An automatic 
biochemical analyser (BS-420) and biochemical kits were purchased from ShenZhen Mindray Bio-medical Electronics Co., Ltd. An 
automatic microplate reader was provided by Molecular Devices, Inc. (USA). Antioxidant enzyme kits were purchased from Nanjing 
Jiancheng Bioengineering Institute (Nanjing, China), and an inflammatory cytokines kit and reagents were provided by RayBiotech, 
Inc. (Guangzhou, China). Ethanol, petroleum ether, ethyl acetate extract, and n-butyl alcohol were purchased from Fuyu Chemical 
Co., Ltd. (Tianjin, China). 
 
Animals  
 
Young mice weighing 18-22 g were purchased from the Animal Physiology Laboratory of Lanzhou University, and a total of 
36 male and 36 female 5-week-old Sprague-Dawley (SD) rats were supplied by the production facility of the Animal Physiology 
Laboratory, Gansu University of Traditional Chinese Medicine (Gansu, China). The accession number is GTCM-140823. The 
animals were fed in a separate room with a barrier system under a controlled light-dark cycle (12-12 h, lights on 7:00-19:00), 
ventilation (air exchange rate of 18 cycles/h), temperature (23±2 °C) and relative humidity (55±15%) during the study. The cages 
and chip bedding were changed twice per week. The experiments began after the rats had acclimatized for one week. This study was 
performed in accordance with the rulings of Gansu Experimental Animal Center (Gansu, China) approved by the Ministry of Health, 
P.R. China, in accordance with NIH guidelines.  
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Plant Material   
 
All the Aster tataricus root material used in this study were collected from The Yellow River Medicine Market (GanSu, China). 
Plant samples were identified by Professor Jifang Zheng at the Lanzhou Institute of Husbandry and Pharmaceutical Sciences of 
CAAS (Sample No. TONE-140512).  
One thousand grams of Aster tataricus L. f. was weighed and added to water-diluted ethanol (purified water 25% v/v and 
ethanol 75% v/v) by three iterations of steam distillation over 2 hrs, filtered, and concentrated to remove the alcohol at 45 °C in a 
rotary evaporator. Next, an equal amount of ether petroleum (60-90 °C) that had been extracted 3 times was added to the 75% 
ethanol extract using a merged extraction and concentrated to a paste with a weight of 6.885 g (0.68% yield) to generate a petroleum 
ether extract of Aster tataricus L. f. (PEA) (Ye et al., 2014).  
The lower aqueous phases were extracted 3 times with an equal amount of ethyl acetate using a merged extraction and 
concentrated to a paste with a weight of 13.529 g (1.35% yield) to generate an ethyl acetate extract of Aster tataricus L. f. (EEA). 
The remaining aqueous phases were extracted 3 times with equal n-butyl alcohol using a merged extraction and concentrated to a 
paste with a weight of 42.493 g (4.25% yield) to generate an n-butyl alcohol extract of Aster tataricus L. f. (NEA). The remaining 
lower aqueous phases were evaporated to a paste under reduced pressure to obtain 397.045 g (39.70% yield) to generate REA.(PEA, 
EEA, NEA, REA extract from AEA) 
Aster tataricus L. f. (100 g) was extracted with 75% ethanol (400 mL of solvent ×3, 2 hrs per extraction) using a reflux unit, 
and the filtered solutions were combined and evaporated to a paste under reduced pressure at 40 °C to eliminate the alcohol, 
resulting in 48.002 g of alcohol extract (48.00% yield), or AEA. AEA was kept at −20 °C until use and suspended in distilled water. 
 
Acute oral toxicity in mice   
 
Sixty healthy Kunming mice (equal numbers of males and females, weighing 18-22 g) were randomly divided into 6 groups, 
with 5 males and 5 females in each group. AEA was dissolved to different concentrations in distilled water and administered to the 
Kunming mice via oral gavage at doses of 25.08, 20.81, 17.27, 14.34, 11.90 or 9.88 g/kg body weight per day at a dose ratio of 0.83 
according to Research Methodology of Traditional Chinese Medicine Pharmacology (People’s Medical Publishing House, 2006) 
(Chen, 2006).  All of the mice were fasted overnight to eliminate food from the gastrointestinal tract before dosing. After gavage, 
the mice were observed for 14 days to observe symptoms, mortality, and changes in behaviour, skin, eyes, fur and somatic motor 
activity. After the experiment, all of the mice were euthanized, and their vital organs were individually observed for overt pathology 
by necropsy. Finally, the LD50 was calculated using SPSS 17.0 software.  
 
Subchronic oral toxicity test  
Experimental design 
 
The five extracts were ground in Tween-80, dissolved in 0.5% water carboxymethyl cellulose Na and administered to the rats 
at a dose of 0.34 g original drug/kg/d.BW. Tween-80 and 0.5% water carboxymethyl cellulose Na were chosen because of their inert 
nature and the insolubility of PEA, EEA, and NEA. The rats were divided into 6 groups (PEA group, EEA group, NEA group, REA 
group, AEA group, and Control group). The treatment groups received Aster tataricus L. f. extract at a dose of approximately 0.34 
g/kg body weight (50/LD50), and the control group received an equal dose of 0.5% carboxymethyl cellulose Na. Both the treatment 
and control groups were dosed daily between 9:00 am and 12:00 am for 13 consecutive weeks.  
Urine samples were collected for analysis at the end of the experiment. On the last day of the experiment, the animals were 
fasted overnight. Before collecting blood, the rats received a 3% sodium pentobarbital solution. Blood was collected on day 92 in 
10% ethylenediaminetetraacetic acid (EDTA) tubes for haematology and in non-oxalate tubes for serum separation. The abdominal 
cavity was opened to dissect out and weigh the liver, lungs, kidneys, heart, spleen, thymus, testes and ovaries. 
 
Peng et al., Afr J Tradit Complement Altern Med. (2016) 13(6):38-53 
10.21010/ajtcam. v13i6.8 
41 
 
Observation of gross toxicity and Urine examination  
 
All the animals were observed twice daily for mortality. General observations were made for clinical signs including 
behavioural changes, signs of gross toxicity, fur condition and somatic motor activity, and these observations were performed once 
daily during the subchronic toxicity study. 
On day 91, each rat was placed in a metabolic cage from 2:00-4:00 pm to collect urine. Urine colour, turbidity, pH, specific 
gravity (USG), protein, nitrite, bilirubin, urobilinogen, ketones, WBC, vitamin C and glucose levels were analysed using a KNF-100 
Automated Urine Chemistry Analyser. 
 
Body weight and food consumption  
 
The animals were weighed on the first day of administration, and then individual body weights and food consumption were 
recorded every day. The mean weekly body weight gain and food consumption were calculated for each sex and measured weekly. 
The rats were allowed unlimited access to food throughout the study. 
 
Macroscopic examination and relative organ weights 
  
The rats were euthanized by administering sodium pentobarbital at dose of 30 mg/kg BW. The abdominal cavity of each rat 
was opened to observe the position, shape, size, colour, and consistency of the organs. Gross lesions were examined in all of the 
animals in all groups. The animals were eviscerated concomitantly. The liver, kidneys, spleen, lungs, heart, thymus, ovaries and 
testes were weighed. A portion of the liver (approximately 0.2-0.5 g) was immediately preserved at -80 °C for liver biochemical and 
cytokine analyses. The absolute organ weights were converted to relative organ weights based on the organ-to-body weight ratio. 
 
Haematology and Serum Biochemistry 
   
After the collection of blood in anticoagulant tubes on day 92, haematology indices were detected by using a pocH-100iV 
haematology analyser and reagents. The indices consisted of white blood cell (WBC), red blood cell (RBC), and platelet (PLT) 
counts; haematocrit (HCT); mean corpuscular volume (MCV); haemoglobin (HGB); mean corpuscular haemoglobin (MCH); and 
mean corpuscular haemoglobin concentration (MCHC). 
Serum was isolated from non-anticoagulated tubes by centrifugation (Xiang Yi L-550, Changsha, China) at 3000 r/min for 15 
min. Measurements of the following were obtained: creatinine (CREA-j), lactate dehydrogenase (LDH), high-density lipoprotein 
cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total bilirubin (T-BIL), alanine aminotransferase (ALT), alkaline 
phosphatase (ALP), aspartate aminotransferase (AST), total protein (TP), albumin (ALB), urea, glucose (GLU), total cholesterol 
(TC), triglycerides (TG), and creatine kinase (CK).  
 
Liver biochemical analysis   
 
The supernatant was isolated from the liver-water suspension (volume ratio liver: water=1:9). GSH, MDA, and T-SOD tests 
were conducted with the liver supernatant according to the instructions provided with the kits. 
 
Histopathology   
 
After weighing the collected organs, all of the samples were fixed in 10% buffered formalin. The histological analysis aimed to 
assess the tissue integrity of the organs and to observe the presence of degeneration, necrosis, apoptosis, leukocyte infiltration, 
congestion, blood extravasation or fibrosis. 
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Quantitative measurements of liver inflammation using an array  
  
Cytokines (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-13, MCP-1, IFNγ, TNFα) were detected by fluorescence with a laser 
scanner using a Cy3 equivalent dye (Watanabe et al., 2005) between the control group, PEA and EEA group. Hepatic tissues were 
homogenized with 10 L protease inhibitors and 990 L 1X Cell Lysis Buffer and then centrifuged at 13,000 rpm for 20 min. The 
supernatants were used for the experiment. Cytokine standard dilutions were prepared before the test according to the kit instructions, 
and all of the kits and reagents were provided by RayBiotech, Inc., Guangzhou. 
 
Statistical analysis  
 
The LD50 values and data on weekly body weight, food consumption, relative organ weights, haematology, serum 
biochemistry, urinalysis and liver assessments were evaluated by one-way ANOVA using SPSS 17.0 statistical software. All of the 
values are expressed as the mean ± SD. P values less than 0.05 were considered significant. 
 
Results  
Acute toxicity    
 
All of the mice were observed for mortality and changes in behavioural patterns over 14 days. The mice became drowsy and 
depressed after dosing, and their fur lost its gloss. (Table 1) shows the group mortality rates. The LD50 of AEA in the mice was 15.74 
g/kg·bw based on calculations performed using Bliss in SPSS 17.0. The mice were convulsive before they died. The organs 
exhibited no macroscopic signs of toxicity, except in the liver. Significant pathological changes and lesions were observed in the 
liver. 
Table 1: Mice mortality in the acute toxicity study. 
Groups Doses (g/kg) Number of mice Mortality  Survival rate (%) 
1 25.08 10 10 0 
2 20.81 10 8 20 
3 17.27 10 5 50 
4 14.34 10 5 50 
5 11.90 10 2 80 
6 9.88 10 0 100 
 
Subchronic toxicity 
Observations of gross toxicity and mortality 
    
No deaths were observed throughout the experimental period. Compared with the solvent group, rats in the PEA, EEA, and 
NEA groups were drowsy and depressed, reacted slowly to outside stimulation, and displayed some fur loss beginning at 21 days 
after oral administration. No significant changes were observed in the remaining groups. These results suggest that the 
administration of PEA, EEA, and NEA in rats at levels up to 0.34 g/kg/day for 91 days have adverse effects on clinical observations. 
 
Food consumption, body weight gain and relative organ weights   
 
The gain in body weight was significantly higher (P < 0.05) in males of the petroleum ether extract group compared with the 
male controls at week 2 (no significant difference was observed in females). However, significant decreases in body weight gain 
relative to male controls were observed in males of the PEA group at weeks 7, 9, 11, and 12 (P < 0.05). In addition, almost all of the 
treatment groups lost weight sporadically from week 7 to week 12. Table 2 and Fig. 1 show the body weight gains and trends in 
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weight gain in the rats. Food consumption is shown in Fig. 2. There were no significant differences in the weekly total food 
consumption between any of the extract groups and the control group throughout the experimental period. This result indicated that 
the Aster tataricus L. f. extracts affected rat weight gain in both sexes during the stable phase (weeks 7 to 12), especially in the 
groups that received the petroleum ether extract and the ethyl acetate extract of Aster tataricus L. f. No significant differences in the 
relative organ weights in either sex were observed between any of the extract groups and the control group (Table 3).  
Table 2: Weekly body weight gain of rat treatment groups at 91 days. 
Time 
Groups 
Control group PEA group EEA group NEA group REA group AEA group 
Male       
1 week 48.00±7.94 53.00±1.41 50.67±9.02 46.50±10.61 53.33±7.51 55.50±2.12 
2 weeks 44.33±6.03 53.50±2.12* 49.67±4.93 49.00±1.41 48.00±3.00 46.50±0.71 
3 weeks 42.33±4.16 42.50±3.54 41.67±4.62 40.50±3.54 43.33±5.86 51.00±2.83 
4 weeks 32.30±5.51 34.50±2.12 38.33±2.08 35.50±3.54 35.00±7.81 42.00±1.41* 
5 weeks 25.32±5.51 25.00±1.41 28.33±5.51 33.50±7.78 34.44±2.08 30.00±5.66 
6 weeks 25.34±7.64 23.50±2.12 21.00±5.00 18.50±3.54 19.67±6.35 20.00±0.00 
7 weeks 25.67±4.93 14.00±2.82* 18.00±6.08 15.50±0.71* 19.33±5.04 17.50±3.54 
8 weeks 15.67±1.53 10.00±1.41 13.67±3.79 16.50±6.36 10.00±2.65 9.50±0.71 
9 weeks 17.00±5.29 6.50±0.71* 14.00±3.61 11.50±6.36 20.00±6.00 12.00±2.83 
10 weeks 9.00±2.00 4.50±0.71 7.67±2.08 13.50±2.12 18.00±8.66* 14.00±1.41 
11 weeks 12.33±5.03 20.00±4.24* 16.33±3.51 16.00±0.00 23.67±3.06** 19.00±1.41 
12 weeks 11.33±1.53 4.50±0.50* 5.33±0.0.58* 16.50±0.71 12.00±5.29 13.50±2.12 
13 weeks 8.00±1.02 9.00±1.41 8.00±2.00 5.50±0.72 5.65±1.52 6.50±0.72 
Female       
1 week 38.50±4.95 37.00±2.65 26.50±4.95* 38.67±6.11 39.50±0.71 33.00±1.73 
2 weeks 21.50±4.95 24.33±2.08 21.00±1.41 26.67±4.51 22.00±5.66 17.33±0.58 
3 weeks 17.00±0.00 15.00±3.00 13.50±3.54 15.67±1.15 19.50±2.12 21.33±3.21 
4 weeks 12.00±2.83 18.33±8.38 14.00±4.24 14.33±6.02 10.50±4.95 12.67±2.52 
5 weeks 16.00±1.41 15.32±2.89 12.50±4.95 17.67±2.08 13.00±1.41 11.00±1.73 
6 weeks 11.50±0.71 12.00±1.00 10.00±1.41 13.67±3.52 13.00±2.83 10.00±3.00 
7 weeks 7.00±1.41 6.33±1.53 3.50±0.71* 10.33±1.53* 10.00±1.41 9.67±1.53 
8 weeks 5.50±0.71 2.33±0.58** 2.00±1.41** -1.33±0.58** -1.50±0.71** 3.33±1.15** 
9 weeks 6.50±0.71 9.00±3.00 2.50±0.71 10.00±3.61 3.50±0.71 5.30±1.00 
10 weeks 9.50±2.12 2.67±1.15** 7.50±2.12 6.67±1.53 6.00±1.41* 4.33±1.15** 
11 weeks 1.50±0.71 7.33±2.31** 1.50±0.71 5.00±1.00* 3.00±1.41 3.67±1.15 
12 weeks 7.50±2.12 0.67±0.26** 5.50±0.71* 1.33±0.58** 4.00±1.41** 0.33±0.15** 
13 weeks 2.50±0.80 3.00±1.00 1.75±0.35 1.35±0.58 3.50±0.72 3.00±1.00 
Values are the mean ± SD for 6 rats in each group. * indicates a significant difference from controls (P < 0.05). ** indicates a highly 
significant difference from controls (P < 0.01). 
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Figure 1: Body weight changes in rats over 91 days. 
The weekly average body weights (g) of male and female rats that received Aster tataricus L. f. extracts. * = statistically significant 
difference in body weight gain compared with the control group. 
 
 
Figure 2: Average weekly food consumption. 
Values are presented as the mean ± SD (6 rats/sex/group). * = significant difference compared with the control group at P < 0.05. 
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Table 3: Effects of different Aster tataricus L. f. extracts on relative organ weights  
Parameters 
Groups 
Control group PEA group EEA group NEA group REA group AEA group 
Male       
Liver 2.91±0.06 2.68±0.29 2.64±0.28 2.79±0.05 2.77±0.05 2.73±0.12 
Heart 0.32±0.02 0.36±0.04 0.31±0.03 0.35±0.01 0.32±0.02 0.33±0.04 
Spleen 0.17±0.04 0.15±0.02 0.16±0.01 0.15±0.03 0.17±0.00 0.15±0.03 
Lungs 0.44±0.02 0.45±0.01 0.43±0.06 0.49±0.06 0.41±0.00 0.47±0.06 
Kidneys 0.65±0.08 0.59±0.07 0.61±0.00 0.67±0.03 0.60±0.02 0.70±0.09 
Thymus 0.10±0.02 0.12±0.06 0.11±0.02 0.12±0.02 0.10±0.01 0.14±0.03 
Testes or ovaries 0.81±0.03 0.87±0.03 0.80±0.06 0.77±0.04 0.74±0.05 0.79±0.02 
Female       
Liver 2.93±0.18 2.68±0.29 2.79±0.13 3.05±0.06 2.90±0.03 3.01±0.35 
Heart 0.36±0.04 0.37±0.04 0.40±0.03 0.41±0.05 0.38±0.03 0.41±0.04 
Spleen 0.19±0.02 0.21±0.03 0.22±0.03 0.22±0.03 0.21±0.03 0.20±0.01 
Lungs 0.53±0.05 0.55±0.01 0.63±0.03 0.55±0.10 0.60±0.04 0.58±0.05 
Kidneys 0.68±0.03 0.64±0.06 0.63±0.03 0.69±0.02 0.66±0.03 0.68±0.04 
Thymus 0.16±0.04 0.17±0.00 0.15±0.07 0.18±0.01 0.14±0.02 0.15±0.01 
Testes or ovaries 0.048±0.01 0.046±0.01 0.046±0.01 0.046±0.01 0.047±0.00 0.050±0.01 
Values are the mean ± SD for 6 rats in each group. * indicates a significant difference from controls (P < 0.05). ** indicates a highly 
significant difference from controls (P < 0.01). 
 
Urine examination    
 
Following urine collection, the urine was observed to be luminous yellow in colour. The quantitative analyses of urine revealed 
no significant differences between any of the extract-treated groups and the control group in either sex. The urine parameters 
examined included pH (6.5-8.0), specific gravity (1.030), nitrite, glucose, protein, bilirubin, urobilinogen (3.3 μmol/L), ketones, 
WBC and vitamin C. 
 
Haematology    
 
No significant changes were observed in any haematological index except MCHC (Table 4). MCHC was decreased in females 
of the PEA, NEA, and REA groups relative to controls.  
 
Table 4: Haematological parameters of Sprague-Dawley rats treated orally with Aster tataricus L. f. extracts 
Parameters 
Groups 
Control group PEA group EEA group NEA group REA group AEA group 
Males       
WBC (109/L) 9.70±0.57 8.65±2.19 11.37±1.79 11.65±0.07 11.13±0.80 8.90±0.14 
RBC (1012/L) 8.11±0.39 8.59±0.58 8.51±0.53 8.50±0.33 8.26±0.35 8.38±0.62 
HGB (g/L) 175.67±9.07 180.50±4.95 180.00±6.00 176.00±5.66 175.67±3.06 178.50±4.95 
HCT 0.46±0.02 0.48±0.02 0.49±0.03 0.48±0.01 0.48±0.01 0.48±0.03 
MCV (fL) 57.33±1.19 55.15±0.07 55.17±1.91 56.55±3.04 57.70±1.40 57.10±1.13 
MCH (pg) 21.67±0.15 20.35±0.49 20.33±0.57 20.75±1.48 21.27±0.67 21.30±0.99 
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MCHC (g/L) 378.00±6.55 370.00±9.90 374.67±6.66 366.50±6.36 368.67±3.21 373.00±9.90 
PLT (109/L) 1068.67±24.01 1138.00±80.61 1183.50±61.52 1052.00±189.50 877.67±32.53 1056.00±34.65 
Females       
WBC (109/L) 6.83±0.22 7.43±0.55 5.75±0.21 9.13±2.93 9.15±1.48 8.20±0.20 
RBC (1012/L) 7.76±0.24 8.19±0.14 7.81±0.20 8.26±0.28 8.04±0.76 8.09±0.36 
HGB (g/L) 172.60±6.02 183.00±8.19 167.00±5.66 173.00±3.61 169.50±10.61 178.00±10.15 
HCT (%) 0.45±0.01 0.47±0.03 0.45±0.01 0.47±0.00 0.47±0.03 0.47±0.03 
MCV (fL) 58.16±0.80 60.40±2.45 57.05±0.07 56.70±1.47 58.00±1.56 58.20±1.18 
MCH (pg) 22.24±0.11 22.33±1.36 21.40±0.14 21.27±0.29 21.10±0.71 22.00±0.62 
MCHC (g/L) 382.60±6.88 369.67±7.09* 375.00±2.83 369.67±5.86* 364.50±2.12** 378.00±13.45 
PLT (109/L) 944.40±78.74 1021.67±139.95 1004.00±83.44 1029.00±71.63 945.00±4.24 914.33±116.14 
Values are the mean ± SD for 6 rats in each group. * indicates a significant difference from controls (P < 0.05). ** indicates a highly 
significant difference from controls (P < 0.01). 
 
Serum chemistry  
   
The results of biochemical analyses of blood are presented in Table 5. In male rats, the administration of each of the five 
extracts of Aster tataricus L. f. resulted in significant increases in CK, and similar trends were observed for the levels of ALT, AST, 
LDL-C, HDL-C, and TC in the PEA group. A significant increase in CK relative to controls was also noted in females in all of the 
tested groups. The plasma levels of ALT in female rats treated with PEA increased relative to the controls. Other parameters that 
showed relative increases were T-BIL (EEA and REA groups), LDH (PEA, EEA, NEA, and REA groups), and TC (AEA group). 
However, ALP was decreased in the PEA and AEA groups compared with the controls. The changes in ALT, AST, ALP, T-BIL, 
and CK indicate liver damage; other activities were not considered in any of the liver toxicological significance tests, although some 
irrelevant changes were observed. 
 
Table 5: Serum biochemistry of SD rats treated orally with Aster tataricus L. f. extracts 
Values are the mean ± SD for 6 rats in each group. * indicates a significant difference from controls (P < 0.05). ** indicates a highly 
significant difference from controls (P < 0.01 
Indices 
Groups 
Control group PEA group EEA group NEA group REA group AEA group 
Male       
ALT (U/L) 46.67±2.31 78.00±26.87* 57.67±14.05 53.50±2.12 57.33±10.79 47.00±7.07 
AST (U/L) 116.33±15.95 175.50±41.72* 142.00±32.08 155.5±3.54 147.67±15.31 125.00±42.23 
ALP (U/L) 155.67±13.43 149.50±2.12 150.00±19.52 124.00±16.97 143.67±29.54 132.50±19.09 
T-BIL (μmol/L) 6.05±1.75 7.55±1.93 5.71±0.17 4.65±0.01 5.51±0.43 5.25±0.66 
TP (g/L) 67.00±2.50 74.10±2.62 69.27±0.80 61.55±4.74 64.60±4.25 66.45±3.04 
ALB (g/L) 34.17±2.59 37.30±2.26 35.77±0.46 33.15±1.91 34.10±1.65 34.35±0.21 
CK (U/L) 654.67±54.00 1958.50±468.81** 1745.00±87.73** 1281.00±2.83** 1982.33±112.22** 1884.00±100.41** 
LDL-C(mmol/L) 0.26±0.04 0.42±0.03** 0.28±0.03 0.28±0.04 0.25±0.06 0.25±0.05 
LDH (U/L) 1146.67±381.34 1458.00±386.08 1179.67±310.78 1641.00±21.21 1258.00±416.45 1274.00±490.73 
Urea (mmol/L) 6.57±1.19 5.95±2.33 6.10±0.26 7.50±0.14 7.83±2.48 6.50±1.84 
Creatinine 
(μmol/L) 
64.33±8.62 74.50±6.36 74.00±5.29 62.00±1.41 66.33±3.79 60.50±2.12 
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Liver biochemical analysis 
    
Results of the liver biochemical analysis are summarized in Table 6. No significant changes were observed in glutathione 
(GSH), total superoxide dismutase (T-SOD), or malondialdehyde (MDA) activities in any of the groups compared with the control 
group.  
Table 6: Liver biochemical indices during the 91-day subchronic oral administration test 
Indices 
Groups 
Solvent group PEA group EEA group NEA group REA group AEA group 
Male       
GSH 25.62±0.98 26.96±3.47 28.49±3.73 28.99±3.80 29.11±3.50 30.71±7.83  
T-SOD 474.09±24.50 541.95±8.20 519.43±55.29 491.70±79.83 504.78±63.11 539.40±113.07 
MDA 1.00±0.25 1.04±0.34 0.75±0.10 0.90±0.08 1.01±0.16 0.83±0.03 
Female       
GSH 23.77±0.39 24.40±4.75 26.62±3.20 25.34±3.09 26.48±1.19 27.00±1.71 
T-SOD 550.76±54.73 563.32±21.43 572.90±14.50 512.50±36.71 497.35±49.92 528.36±62.98 
MDA 1.11±0.04 1.17±0.05 1.19±0.06 0.96±0.06 1.17±0.21 1.10±0.03 
Values are the mean ± SD for 6 rats in each group. * indicates a significant difference from controls (P < 0.05). ** indicates a highly 
significant difference from controls (P < 0.01).  
 
Quantitative measurement of cytokines    
 
There were no significant differences in cytokine measurements (Fig. 3). The alignment of the cytokine arrays is shown in Fig. 
HDL-C (mmol/L) 1.07±0.15 1.61±0.24* 1.10±0.05 1.12±0.17 1.19±0.22 1.02±0.36 
Glucose (mmol/L) 5.72±0.83 5.29±1.53 4.74±0.34 6.10±0.56 5.33±0.59 5.37±1.02 
TC (mmol/L) 1.60±0.30 2.30±0.28* 1.63±0.15 1.60±0.28 1.67±0.32 1.70±0.14 
TG (mmol/L) 1.05±0.13 1.15±0.07 1.30±0.49 0.75±0.07 1.20±0.18 1.21±0.07 
Female       
ALT (U/L) 45.50±4.95 58.67±2.52* 45.50±2.12 50.33±5.51 45.50±3.54 47.33±11.01 
AST (U/L) 131.40±32.74 141.00±30.12 156.50±24.75 152.67±43.59 140.00±36.77 116.33±23.29 
ALP (U/L) 112.50±0.71 91.67±4.93** 99.50±0.71 109.33±11.72 100.00±1.41 89.00±4.00** 
T-BIL (μmol/L) 4.97±1.31 5.48±0.92 7.12±0.14* 4.96±0.66 7.53±0.79* 5.19±1.06 
TP (g/L) 72.24±7.50 71.47±4.48 72.65±1.77 67.53±1.46 65.65±3.75 72.50±1.23 
ALB (g/L) 37.70±2.27 37.43±0.91 36.80±0.85 35.93±0.64 34.85±2.62 38.03±1.36 
CK (U/L) 1544.50±286.48 2548.33±458.26** 4490.50±441.94** 3010.00±284.96** 3084.50±665.39** 2521.67±487.26* 
LDL-C (mmol/L) 0.21±0.06 0.27±0.04 0.26±0.01 0.24±0.05 0.27±0.01 0.27±0.07 
LDH (U/L) 683.67±32.32 1206.67±212.59** 1347.50±178.90** 1265.67±197.00** 1120.00±247.49* 978.67±220.00 
Urea (mmol/L) 7.22±0.43 7.20±1.57 6.65±0.64 6.93±2.14 7.95±1.34 8.10±1.84 
Creatinine 
(μmol/L) 
70.40±9.56 79.67±9.61 72.50±9.19 67.67±7.51 68.00±2.83 70.67±2.52 
HDL-C (mmol/L) 1.81±0.22 1.66±0.42 1.72±0.05 1.65±0.17 1.77±0.54 2.28±0.19 
Glucose (mmol/L) 5.85±1.08 5.07±0.80 4.76±0.08 6.09±0.55 5.56±1.06 5.08±0.57 
TC (mmol/L) 2.24±0.36 2.20±0.46 2.40±0.14 2.10±0.20 2.40±0.57 2.83±0.31* 
TG (mmol/L) 0.94±0.39 1.13±0.22 1.06±0.17 0.76±0.14 0.84±0.23 0.59±0.11 
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4A. Examples of the array blots after incubation with liver tissue samples (groups PEA and EEA) are shown in Fig. 4B. Twelve 
positively stained inflammation spots were clearly identified. All of the spots were slightly darker compared to those of the control 
rats, demonstrating that there were no significant changes in the levels of inflammatory cytokines. 
 
Figure 3: Quantitative measurements of cytokines. Values are means ± SEM for 4 rats in each of the PEA, EEA and Control groups. 
*P < 0.05, **P < 0.01 (extract groups vs. controls). 
 
(A) The map of QAR-INF-1 
1 2 3 4 5 6 7 8 
A POS1 POS1 POS1 POS1 POS2 POS2 POS2 POS2 
B IFNg IFNg IFNg IFNg IL-1 a IL-1 a IL-1 a IL-1 a 
C IL-1b IL-1b IL-1b IL-1b IL-2 IL-2 IL-2 IL-2 
D IL-4 IL-4 IL-4 IL-4 IL-6 IL-6 IL-6 IL-6 
E IL-10 IL-10 IL-10 IL-10 IL-13 IL-13 IL-13 IL-13 
F MCP-1 MCP-1 MCP-1 MCP-1 TNFa TNFa TNFa TNFa 
 
   
 
Figure 4: Results of the rat inflammation array. (A) The alignment of 12 cytokines in the Rat Inflammation Array. (B) Examples of 
Rat Inflammation Array blots probed with liver samples from the PEA and EEA groups. 
 
Histopathology   
 
There were no significant macroscopic changes in observable toxicity in the main organs of the extract-treated rats at 91 days. 
However, the histopathological examination of organs from the extract-treated groups revealed sporadic lesions, slight congestion 
and hepatic cord disorders in the liver in the PEA and EEA groups (Fig. 5B, 5C). In addition, signs of swelling and dissolution of the 
cardiac muscle fibres were observed in myocardial cells (Fig. 5H) in the PEA group; however, no significant differences were 
observed between any of the remaining extract-treated groups compared with the controls. No changes in the other organs, including 
the kidneys, spleen, lungs, thymus, ovaries or testes, were detect
(B)    Control group                PEA group                  EEA group 
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                 ( A )                             ( B )                    ( C ) 
   
                 ( D )                             ( E )                     ( F ) 
                                
                             G                          H 
Figure 5: Histopathological photomicrographs obtained at 91 days. 
Photomicrographs of liver tissue from the control group (A) and B,C,D,E,F for PEA, EEA, NEA, REA,ANA group. Image G shows the condition of the heart in normal rats, and H shows that of the 
PEA group. All of the samples were stained with haematoxylin and eosin (40x). 
  
Peng et al., Afr J Tradit Complement Altern Med. (2016) 13(6):38-53 
10.21010/ajtcam. v13i6.8 
50 
 
 
Discussion 
 
In recent years, there has been an increasing emphasis on the safety and efficacy of natural plant products and the elimination 
of side effects. The diversity and complexity of herbal components make it necessary to establish their safety, quality and 
effectiveness (Lee et al., 2012; Shin et al., 2011). We found that Aster tataricus L. f. extracts were toxic to animals and resulted in 
death during a pharmacologic study. Considering its lack of toxicological properties, to clarify the toxicological profile of Aster 
tataricus L. f., an acute toxicity test was conducted. The results demonstrated the toxic effects of Aster tataricus L. f. in mice. The 
LD50 of the 75% ethanol extract was greater than 15.74 g/kg BW in mice, and the detection of liver lesions indicated that Aster 
tataricus L. f. toxicity mainly affected the liver. 
The preliminary hypothesis that Aster tataricus L. f. extracts can cause liver toxicity can be evaluated by examining the nidus 
in the liver. The lack of significant differences in the urine traits between each of the treatment groups and controls demonstrated 
that kidney function was normal in the extract-treated rats. No deaths related to extract administration were noted, but clinical signs 
such as unkempt fur, drowsiness and reduced appetite were observed in the treatment groups during the later period of the 
subchronic toxicity test compared with the control group. Increases or decreases in body weight usually reflect physiological 
changes, such as changes in liver function or hormones. The observed differences in weight gain indicate that these five extracts of 
Aster tataricus L. f., especially the petroleum ether and ethyl acetate extracts, can affect weight gain of rats, potentially via the 
accumulation of toxic effects.  
The haematopoietic system can reflect toxic effects because of its sensitivity to toxic compounds (Adeneye et al., 2006). The 
significant decrease in MCHC observed may be due to diminished cell absorption caused by the accumulation of toxins. Iron 
deficiency can cause a decrease in MCHC values (Patel et al., 2008). Plasma ALT and AST levels are associated with changes in the 
permeability of the hepatocyte membrane or hepatic damage because soluble cytosolic enzymes are released into the blood when the 
permeability of the hepatocellular membrane is altered by either hepatocytic membrane injury or metabolic disturbances (Hor et al., 
2011; Ihsan et al., 2010). Haematological analyses indicate that these phenomena generally result in the elevation of these enzymes 
in the blood. This type of release typically occurs from the apical side of the hepatocyte plasma membrane facing the canaliculi 
(Ramaiah, 2007). Cholestasis increases total serum bilirubin levels.   Therefore, the significant increase in bilirubin observed in 
female rats confirmed the presence of disturbances in liver function because hyperbilirubinaemia caused by drug inhibition results in 
bilirubin transport into hepatocytes or the inhibition of bilirubin conjugation in the liver (Zucker et al., 2001). Lactate dehydrogenase 
(LDH) levels increased in the treated group, and this effect was very clear in females. Lactate dehydrogenase (LDH) leakage has 
been occasionally encountered in the literature as a potential marker of hepatocellular toxicity. Alkaline phosphatase (ALP) is 
considered to be a cholestatic induction enzyme of hepatobiliary origin and shows minimal activity in normal hepatic tissue. ALP is 
generally used to detect impaired bile flow (cholestasis), but serum ALP activity typically increases rapidly in rats following a meal 
due to its high sensitivity, and thus, it cannot be reliably employed to detect cholestasis (Amacher, 2002). Considering the fasting 
employed during the last night of the test and the sensitivity of ALP to fasting, the decrease in ALP observed during the test period 
(a significant difference in female rats in the PEA and AEA groups) is not a good toxicity-related parameter. Increases in CK, LDH, 
and AST are considered to be indicators of myocardial damage. Nevertheless, the measurement of AST, CK, and LDH activities 
involves poor sensitivity and specificity in myocardial tissue, and therefore, the use of these measurements in clinical practice is 
limited. Currently, troponins are used as a replacement (Kulthinee et al., 2010; O'Brien, 2008; Walker, 2006). Hence, the observed 
increases in CK and LDH might only be a reference for myocardial damage, with greater cardiac toxicity observed in female 
compared to male rats. Serum creatine (Crea) and urea levels are used to assess renal toxicity (Kuroiwa et al., 2006), but no 
abnormities were observed in these activities in the present study. The observed increases in LDL-C, HDL-C and cholesterol in 
males in the PEA group suggest that petroleum ether extract of Aster tataricus L. f. affects lipid and carbohydrate metabolism in rats. 
HDL is known to be a strong inverse predictor of cardiovascular disease (Liju et al., 2013). Although some sporadic differences were 
observed, these differences were not considered to be related to toxicity because the observed changes were within the normal 
reference laboratory range (Petterino et al., 2006). Serum chemistry results showed that extracts of Aster tataricus L. f., especially 
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petroleum ether extract, affect liver function and have some effect on the heart. 
The production of excessive free radicals in liver tissue creates tissue injury, resulting in decreases in the levels of SOD and 
GSH. MDA is an important indicator of biological membrane system damage because it is a product of lipid peroxidation, and its 
content can reflect the degree of lipid peroxidation in the body and indirectly reflect the degree of cell injury. However, there were 
no significant changes in the three antioxidases. Furthermore, the results of the cytokine assessment revealed little effect of the 
petroleum ether extract and the ethyl acetate extract on inflammation, although these results may have been caused by 
inter-individual differences in the rats. The lack of obvious differences in these parameters indicated that liver toxicity was not 
severe at the dose of 0.34 g/kg/d·BW. The histopathological results from the selected organs (heart, liver, lungs, spleen, thymus, 
testis, ovaries and kidneys) revealed normal architecture except for the liver in both sexes of group PEA and EEA. Therefore, these 
lesions can be considered to be spontaneous and/or incidental in nature but relevant to Aster tataricus L. f. treatment, especially in 
animals that receive petroleum ether extract or ethyl acetate extract of Aster tataricus L. f. (Lu et al., 2014). 
The administration of low oral doses of Aster tataricus L. f. extracts to rats can cause mild liver injury, whereas the 
administration of high doses can cause acute liver toxicity or death. The results of our tests revealed that the petroleum ether and 
ethyl acetate extracts of Aster tataricus L. f. could cause liver toxicity after 91 days at a daily oral dose of 0.34 g/kg bw. The main 
components in petroleum ether and ethyl acetate extracts are shionone, friedelin, epifriedelinol, chrysophanol, emodin, quercetin, 
and luteolin (Ye, 2007). The pharmacologically active ingredients are also concentrated in these two polar segments; for example, 
shionone is the main active ingredient that eliminates phlegm and relieves cough (Qiny et al., 1984). An experimental study by 
Yanhua Lu et al. (1999) showed that petroleum ether and ethyl acetate extracts could eliminate phlegm. Emodin and quercetin have 
anti-inflammatory and bacteriostasis effects. Considering the toxicity of Aster tataricus L. f., it is important to consider this toxicity 
in clinical settings. Our future research will be focused on identifying drugs or other measures that can potentially inhibit the toxic 
effects of Aster tataricus L. f. to allow full benefit from its pharmacological effects. 
 
 Conclusion 
 
Despite sporadic differences, the toxicity-related changes observed in this study were significant. The results of this study 
showed the toxic effects primarily affected the liver, with slight effects on the heart. The acute oral toxicity experiment showed that 
Aster tataricus L. f. is capable of toxic effects and resulted in an LD50 of 15.74 g/kg BW in mice, The subchronic experiment, 
conducted at a dose of 0.34 g/kg/d.BW, demonstrated that the toxic components of Aster tataricus L. f. were mainly concentrated in 
the petroleum ether fraction, followed by the ethyl acetate fraction, the n-butyl alcohol fraction, the lower aqueous phase and the 
75% ethanol extract.  
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